In spite U87MG glioma cells are not mutant for EGFR, they constitutively activate MAP kinase pathway in virtue of mutations affecting Focal Adhesion Kinases and GRP3 [27, 28]. This evidence concerns the gene EGFR and central nervous system cancer.